Since October 2023, the number of cases of Mpox in New York City has been steadily rising. The health alert issued by the New York City Department of Health and Mental Hygiene (NYC Health) on May 3rd confirmed this trend, stating that the average number of cases per month has increased to 36 since October, with a peak of 51 cases in January. This is a significant increase compared to the previous average of 2 to 20 cases per month.
The majority of these cases have been reported in individuals who have not been vaccinated or have only received one dose. Out of the 256 cases reported since October, 73% were unvaccinated or had only received one dose. Additionally, most cases were mild, with only ten individuals requiring hospitalization. However, it is important to note that some individuals may experience severe symptoms and complications from Mpox infection.
Healthcare providers are being urged by NYC Health to continue offering vaccines to at-risk populations, particularly those with HIV or other immunocompromising conditions. The Jynneos vaccine has transitioned to the commercial market, but federally funded supplies will be available at no cost until early summer. Providers should also be mindful of the risk posed by the more severe clade 1 virus currently causing a severe outbreak in the Democratic Republic of Congo (DRC). While this strain has not been found outside of Africa, healthcare providers should watch for individuals with mpox symptoms who have traveled to or have connections with the affected region.
Overall, it is important for individuals who are unvaccinated or have only received one dose to consider getting vaccinated as soon as possible to protect themselves from further exposure to Mpox infection. Additionally, healthcare providers should be vigilant in monitoring for any signs or symptoms associated with Mpox infection and take appropriate action if necessary.